NCT00442312View on ClinicalTrials.gov

Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy

PHASE4UnknownINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

May 31, 2006

Study Completion Date

November 30, 2006

Conditions
Glaucoma
Interventions
DRUG

Combigan Ophthalmic Solutiom

Trial Locations (1)

Unknown

Allergan, Taipei

Sponsors

Collaborators (1)

Allergan Medical
All Listed Sponsors
collaborator

Allergan Medical

INDUSTRY

lead

Genovate Biotechnology Co., Ltd.,

INDUSTRY